Vascularized lymph node transplantation induces graft-versus-host disease in chimeric hosts

Transplantation

Volumn 81, Issue 10, 2006, Pages 1435-1441

  Francois, Cedric G ^a   Brouha, Pascal C R ^a,b   Laurentin Perez, Luis A ^a   Perez Abadia, Gustavo ^a   Grossi, Federico V ^a   Barker, John H ^a   Hewitt, Charles W ^c   Kon, Moshe ^b   Ramsamooj, Rajendra ^c   Maldonado, Claudio ^a,d  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d Plastic Surgery Research   (United States)

Author keywords

Graft versus host disease; T Lymphocytes; Tumor immunity

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FRACTIONATION; CHIMERA; CONTROLLED STUDY; DISEASE SEVERITY; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; IMMUNE RESPONSE; ISOGRAFT; LYMPH NODE; LYMPH NODE CELL; LYMPH NODE TRANSPLANTATION; MALE; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; TRANSPLANTATION; VASCULARIZATION;

ANIMALS; GRAFT VS HOST DISEASE; GRAFT VS HOST REACTION; LYMPH NODES; LYMPHATIC VESSELS; LYMPHOCYTE CULTURE TEST, MIXED; MALE; RATS; RATS, INBRED ACI; RATS, INBRED WF; TRANSPLANTATION CHIMERA;

EID: 33744922634     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000209210.75211.57     Document Type: Article

References (16)

1. Barker CF, Billingham RE. The role of afferent lymphatics in the rejection of skin homografts. J Exp Med 1968; 128: 197-221.
2. Lakkis FG, Arakelov A, Konieczny BT, et al. Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat Med 2000; 6: 686-688.
3. Davel L, Eijan AM, Sales ME, et al. Reactivity of tumor-draining lymph nodes and the nitric oxide pathway. Int J Oncol 2002; 20: 59-67.
4. Yang G, Mizuno MT, Hellstrom KE, et al. B7-negative versus B7-positive P815 tumor: differential requirements for priming of an antitumor immune response in lymph nodes. J Immunol 1997; 158: 851-858.
5. Schweighoffer T, Schmidt W, Buschle M, et al. Depletion of naive T cells of the peripheral lymph nodes abrogates systemic antitumor protection conferred by IL-2 secreting cancer vaccines. Gene Ther 1996; 3: 819-824.
6. Gorantla VS, Maldonado C, Barker JH. Composite tissue allografts: tolerance induction without graft-versus-host disease. Surg Forum 2000; LI: 578-580.
7. Brouha PC, Perez-Abadia G, Francois CG, et al. Lymphadenectomy prior to rat hind limb allotransplantation prevents graft-versus-host disease in chimeric hosts. Transpl Int 2004; 17: 341-350.
8. Ildstad ST, Sachs DH. Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature 1984; 307: 168-170.
9. Neipp M, Exner BG, Maru D, et al. T-cell depletion of allogeneic bone marrow using anti-alphabetaTCR monoclonal antibody: prevention of graft-versus-host disease without affecting engraftment potential in rats. Exp Hematol 1999; 27: 860-867.
10. Beschorner WE, Tutschka PJ, Santos GW. Sequential morphology of graft-versus-host disease in the rat radiation chimera. Clin Immunol Immunopathol 1982; 22: 203-224.
11. Burakoff SJ, Deeg HJ, Ferrara J, et al. The pathology of acute graft-versus-host disease. In: Snover DC, Dale C, eds. Graft-versus-Host Disease Immunology, Pathophysiology and Treatment. New York: Marcel Dekker, 1990.
12. Briscoe DM, Alexander SI, Lichtman AH. Interactions between T lymphocytes and endothelial cells in allograft rejection. Curr Opin Immunol 1998; 10: 525-531.
13. Pedersen NC, Morris B. The role of the lymphatic system in the rejection of homografts: a study of lymph from renal transplants. J Exp Med 1970; 131: 936-969.
14. Pober JS, Orosz CG, Rose ML, et al. Can graft endothelial cells initiate a host anti-graft immune response? Transplantation 1996; 61: 343-349.
15. Lee WP, Yaremchuk MJ, Pan YC, et al. Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg 1991; 87: 401-411.
16. Jones ND, Turvey SE, Van Maurik A, et al. Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection. J Immunol 2001; 166: 2824-2830.